{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:41:37Z","timestamp":1784619697745,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T00:00:00Z","timestamp":1368748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12253-013-9647-8","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T17:41:37Z","timestamp":1368726097000},"page":"805-810","source":"Crossref","is-referenced-by-count":7,"title":["Risk of Subsequent Primary Tumor Development in Melanoma Patients"],"prefix":"10.1007","volume":"19","author":[{"given":"Veronika","family":"T\u00f3th","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Hatvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Somlai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"H\u00e1rsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos F.","family":"L\u00e1szl\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarolta","family":"K\u00e1rp\u00e1ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"key":"9647_CR1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.1996.45","volume":"73","author":"C Wassberg","year":"1996","unstructured":"Wassberg C, Th\u00f6rn M, Yuen J, Ringborg U, Hakulinen T (1996) Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 73:255\u2013259","journal-title":"Br J Cancer"},{"key":"9647_CR2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<776::AID-IJC12>3.0.CO;2-7","volume":"72","author":"F Levi","year":"1997","unstructured":"Levi F, LaVecchia C, Randimbison L, Te VC, Erler G (1997) Incidence of invasive cancers following cutaneous malignant melanoma. Int J Cancer Suppl 72:776\u2013779","journal-title":"Int J Cancer Suppl"},{"key":"9647_CR3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/(SICI)1097-0215(19991029)83:3<314::AID-IJC5>3.0.CO;2-9","volume":"83","author":"C Wassberg","year":"1999","unstructured":"Wassberg C, Thorn M, Yuen J, Hakulinen T, Ringborg U (1999) Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ. Int J Cancer 83:314\u2013317","journal-title":"Int J Cancer"},{"key":"9647_CR4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1524-4725.2000.99292.x","volume":"26","author":"G Kroumpouzos","year":"2000","unstructured":"Kroumpouzos G, Konstadoulakis MM, Cabral H, Karakousis CP (2000) Risk of basal cell and squamous cell carcinoma in persons with prior cutaneous melanoma. Dermatol Surg 26:547\u2013550","journal-title":"Dermatol Surg"},{"key":"9647_CR5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/1097-0142(20010215)91:4<874::AID-CNCR1076>3.0.CO;2-O","volume":"91","author":"WB Goggins","year":"2001","unstructured":"Goggins WB, Finkelstein DM, Tsao H (2001) Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 91:874\u2013880","journal-title":"Cancer"},{"key":"9647_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1365-2133.2001.04507.x","volume":"145","author":"MH Schmid-Wendtner","year":"2001","unstructured":"Schmid-Wendtner MH, Baumert J, Wendtner CM, Plewig G, Volkenandt M (2001) Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 145:981\u2013985","journal-title":"Br J Dermatol"},{"key":"9647_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00008469-200402000-00006","volume":"13","author":"E Crocetti","year":"2004","unstructured":"Crocetti E, Carli P (2004) Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev 13:33\u201337","journal-title":"Eur J Cancer Prev"},{"key":"9647_CR8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdi080","volume":"16","author":"MB Lens","year":"2005","unstructured":"Lens MB, Newton-Bishop JA (2005) An association between cutaneous melanoma and non-Hodgkin\u2019s lymphoma: pooled analysis of published data with a review. Ann Oncol 16:460\u2013465","journal-title":"Ann Oncol"},{"key":"9647_CR9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-4632.2005.02640.x","volume":"45","author":"YH Wu","year":"2006","unstructured":"Wu YH, Kim GH, Wagner JD, Hood AF, Chuang TY (2006) The association between malignant melanoma and noncutaneous malignancies. Int J Dermatol 45:529\u2013534","journal-title":"Int J Dermatol"},{"key":"9647_CR10","volume-title":"New malignancies among cancer survivors: SEER cancer registries, 1973-2000","author":"DM Freedman","year":"2006","unstructured":"Freedman DM, Miller BA, Tucker MA (2006) New malignancies following melanoma of skin, eye melanoma, and nonmelanoma eye cancer. In: Curtis RE, Freedman DM, Ron E et al (eds) New malignancies among cancer survivors: SEER cancer registries, 1973-2000. National Cancer Institute, Bethesda"},{"key":"9647_CR11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/CMR.0b013e3282fafd0a","volume":"18","author":"E Crocetti","year":"2008","unstructured":"Crocetti E, Guzzinati S, Paci E, Falcini F, Zanetti R, Vercelli M et al (2008) The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries). Melanoma Res 18:230\u2013234","journal-title":"Melanoma Res"},{"key":"9647_CR12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.bjc.6604842","volume":"100","author":"MM Cantwell","year":"2009","unstructured":"Cantwell MM, Murray LJ, Catney D, Donnelly D, Autier P, Boniol M et al (2009) Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland. Br J Cancer 100:174\u2013177","journal-title":"Br J Cancer"},{"key":"9647_CR13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaad.2009.07.039","volume":"62","author":"JP Spanogle","year":"2010","unstructured":"Spanogle JP, Clarke CA, Aroner S, Swetter SM (2010) Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. J Am Acad Dermatol 62:757\u2013767","journal-title":"J Am Acad Dermatol"},{"key":"9647_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","volume":"146","author":"PT Bradford","year":"2010","unstructured":"Bradford PT, Freedman DM, Goldstein AM, Tucker MA (2010) Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 146:265\u2013272","journal-title":"Arch Dermatol"},{"issue":"5 Suppl 1","key":"9647_CR15","first-page":"69","volume":"65","author":"A Balamurugan","year":"2011","unstructured":"Balamurugan A, Rees JR, Kosary C, Rim SH, Li J, Stewart SL (2011) Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin. J Am Acad Dermatol 65(5 Suppl 1):69\u201377","journal-title":"J Am Acad Dermatol"},{"key":"9647_CR16","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2014::AID-CNCR19>3.0.CO;2-4","volume":"86","author":"S Bhatia","year":"1999","unstructured":"Bhatia S, Estrada-Batres L, Maryon T, Bogue M, Chu D (1999) Second primary tumors in patients with cutaneous malignant melanoma. Cancer 86:2014\u20132020","journal-title":"Cancer"},{"key":"9647_CR17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1468-3083.2000.00162.x","volume":"14","author":"J Wolff","year":"2000","unstructured":"Wolff J, Wollina U (2000) Second malignancies in melanoma patients in Thuringia. J Eur Acad Dermatol Venereol 14:479\u2013483","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9647_CR18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2230.2012.04455.x","volume":"37","author":"AM Manganoni","year":"2012","unstructured":"Manganoni AM, Pavoni L, Farisoglio C, Sereni E, Chiudinelli M, Calzavara-Pinton P (2012) Association between multiple cutaneous melanoma and other primary neoplasms. Clin Exp Dermatol 37:857\u2013861","journal-title":"Clin Exp Dermatol"},{"key":"9647_CR19","unstructured":"National Cancer Registry (2001-2010) National Institute of Oncology http:\/\/www.honcology.hu\/portal\/page\/portal\/OOI\/MEDICAL_ATTENDANCE\/medical_departments\/MD_901\/Statisztika"},{"key":"9647_CR20","volume-title":"Epidemiologic analysis with a programmable calculator (NIH publication 79-1649)","author":"KJ Rothman","year":"1979","unstructured":"Rothman KJ, Boice JD (1979) Epidemiologic analysis with a programmable calculator (NIH publication 79-1649). US Government Printing Office, Washington DC"},{"key":"9647_CR21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/14786440009463897","volume":"50","author":"K Pearson","year":"1900","unstructured":"Pearson K (1900) On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Philos Mag 50:157\u2013175","journal-title":"Philos Mag"},{"key":"9647_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2307\/2983604","volume":"1","author":"F Yates","year":"1934","unstructured":"Yates F (1934) Contingency table involving small numbers and the \u03c7 2 test. Suppl J R Stat Soc 1:217\u2013235","journal-title":"Suppl J R Stat Soc"},{"key":"9647_CR23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jaad.2012.02.042","volume":"67","author":"KA Ward","year":"2012","unstructured":"Ward KA, Lazovich D, Hordinsky MK (2012) Germline melanoma susceptibility and prognostic genes: a review of the literature. J Am Acad Dermatol 67:1055\u20131067","journal-title":"J Am Acad Dermatol"},{"key":"9647_CR24","author":"J Read","year":"2013","unstructured":"Read J (2013) Recent advances in cutaneous melanoma: towards a molecular model and targeted treatment. Australas J Dermatol. doi: 10.1111\/ajd.12013","journal-title":"Australas J Dermatol"},{"key":"9647_CR25","doi-asserted-by":"crossref","unstructured":"Boussemart L, Routier E, Mateus C, Opletalova K, Sebille G, Kamsu-Kom N et al (2013) Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol 2013 Feb 13. [Epub ahead of print]","DOI":"10.1093\/annonc\/mdt015"},{"key":"9647_CR26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","volume":"366","author":"F Su","year":"2012","unstructured":"Su F, Viros A, Milagre C, Trunzer K, Bollag G, Spleiss O et al (2012) RAS mutations in cutaneous squamous-cell carcionomas in patients treated with BRAF inhibitors. N Engl J Med 366:207\u2013215","journal-title":"N Engl J Med"},{"key":"9647_CR27","first-page":"847","volume":"25","author":"PB Chapman","year":"2012","unstructured":"Chapman PB et al (2012) Development of colonic adenomas and gastric polyps in BRAF mutant melanoma patients treated with vemurafenib. Pigment Cell Melanoma Res 25:847","journal-title":"Pigment Cell Melanoma Res"},{"key":"9647_CR28","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa1208958","volume":"367","author":"MK Callahan","year":"2012","unstructured":"Callahan MK, Rampal R, Harding JJ, Klimek VM, Chung YR, Merghoub T et al (2012) Progression of RAS-mutant leukemia during RAF inhibitor treatment. N Engl J Med 367:2316\u20132321","journal-title":"N Engl J Med"},{"key":"9647_CR29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrclinonc.2012.215","volume":"10","author":"KS Smalley","year":"2013","unstructured":"Smalley KS, Sondak VK (2013) Targeted therapy for melanoma: is double hitting a home run? Nat Rev Clin Oncol 10:5\u20136","journal-title":"Nat Rev Clin Oncol"},{"key":"9647_CR30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10552-012-9929-6","volume":"23","author":"WB Grant","year":"2012","unstructured":"Grant WB (2012) Ultraviolet exposure and non-Hodgkin\u2019s lymphoma: beneficial and adverse effects? Cancer Causes Control 23:653\u2013655","journal-title":"Cancer Causes Control"},{"key":"9647_CR31","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s10552-011-9849-x","volume":"22","author":"KA Bertrand","year":"2011","unstructured":"Bertrand KA, Chang ET, Abel GA, Zhang SM, Spiegelman D, Qureshi AA et al (2011) Sunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses\u2019 Health Study. Cancer Causes Control 22:1731\u20131741","journal-title":"Cancer Causes Control"},{"key":"9647_CR32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/1871520611307010140","volume":"13","author":"WB Grant","year":"2012","unstructured":"Grant WB (2012) Update on evidence that support a role of solar ultraviolet-B irradiance in reducing cancer risk. Anticancer Agents Med Chem 13:140\u2013146","journal-title":"Anticancer Agents Med Chem"},{"key":"9647_CR33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/cncr.10196","volume":"94","author":"WB Grant","year":"2002","unstructured":"Grant WB (2002) An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 94:272\u2013281","journal-title":"Cancer"},{"key":"9647_CR34","first-page":"2687","volume":"26","author":"WB Grant","year":"2002","unstructured":"Grant WB, Garland CF (2002) The association of solar ultraviolet-B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26:2687\u20132699","journal-title":"Anticancer Res"},{"key":"9647_CR35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1471-2407-6-264","volume":"6","author":"FP Boscoe","year":"2006","unstructured":"Boscoe FP, Schymura MJ (2006) Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993\u20132002. BMC Cancer 6:264","journal-title":"BMC Cancer"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9647-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-013-9647-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9647-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T18:17:46Z","timestamp":1563041866000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-013-9647-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9647"],"URL":"https:\/\/doi.org\/10.1007\/s12253-013-9647-8","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,17]]}}}